Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Sponsor: Charles University, Czech Republic
This observational or N/A phase trial investigates Cervical Cancer and Endometrial Cancer and is currently actively recruiting participants. Charles University, Czech Republic leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
5 versions recorded-
Dec 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Dec 2025 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
-
Dec 2022 — Jul 2024 [monthly]
Recruiting
First recorded
May 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Charles University, Czech Republic
- Karolinska Institutet and Department of Obstetrics and Gynecology, Södersjukhuset, Stockholm, Sweden.
- Policlinico Universitario A. Gemelli, IRCSS, Rome, Italy.
- UZ Leuven, Leuven, Belgium
- Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .